Australian Veterinary Journal

Cover image for Vol. 89 Issue s1

Special Issue: Equine Influenza in Australia in 2007

July 2011

Volume 89, Issue Supplement s1

Pages 1–173

  1. EDITORIAL

    1. Top of page
    2. EDITORIAL
    3. OVERVIEW OF THE OUTBREAK
    4. CLINICAL ASPECTS
    5. LABORATORY ASPECTS
    6. EPIDEMIOLOGY
    7. RESPONSE MANAGEMENT
    8. VACCINATION
    9. SOCIAL AND INDUSTRY ASPECTS
    10. MONITORING AND PROOF OF FREEDOM
    1. FOREWORD (page 2)

      R Glanville

      Version of Record online: 28 JUN 2011 | DOI: 10.1111/j.1751-0813.2011.00723.x

  2. OVERVIEW OF THE OUTBREAK

    1. Top of page
    2. EDITORIAL
    3. OVERVIEW OF THE OUTBREAK
    4. CLINICAL ASPECTS
    5. LABORATORY ASPECTS
    6. EPIDEMIOLOGY
    7. RESPONSE MANAGEMENT
    8. VACCINATION
    9. SOCIAL AND INDUSTRY ASPECTS
    10. MONITORING AND PROOF OF FREEDOM
    1. Diagnosis of equine influenza virus infections in quarantine stations in Australia, 2007 (pages 4–6)

      J Watson, P Selleck, A Axell, K Bruce, T Taylor, H Heine, P Daniels and M Jeggo

      Version of Record online: 28 JUN 2011 | DOI: 10.1111/j.1751-0813.2011.00722.x

    2. The first five days: field and laboratory investigations during the early stages of the equine influenza outbreak in Australia, 2007 (pages 6–10)

      PD Kirkland, RJ Davis, D Wong, D Ryan, K Hart, B Corney, G Hewitson, K Cooper, A Biddle, S Eastwood, S Slattery, D Rayward, M Evers, T Wright, K Halpin, P Selleck and J Watson

      Version of Record online: 28 JUN 2011 | DOI: 10.1111/j.1751-0813.2011.00724.x

  3. CLINICAL ASPECTS

    1. Top of page
    2. EDITORIAL
    3. OVERVIEW OF THE OUTBREAK
    4. CLINICAL ASPECTS
    5. LABORATORY ASPECTS
    6. EPIDEMIOLOGY
    7. RESPONSE MANAGEMENT
    8. VACCINATION
    9. SOCIAL AND INDUSTRY ASPECTS
    10. MONITORING AND PROOF OF FREEDOM
    1. Pathological changes in horses dying with equine influenza in Australia, 2007 (pages 19–22)

      AP Begg, RL Reece, S Hum, W Townsend, A Gordon and J Carrick

      Version of Record online: 28 JUN 2011 | DOI: 10.1111/j.1751-0813.2011.00731.x

  4. LABORATORY ASPECTS

    1. Top of page
    2. EDITORIAL
    3. OVERVIEW OF THE OUTBREAK
    4. CLINICAL ASPECTS
    5. LABORATORY ASPECTS
    6. EPIDEMIOLOGY
    7. RESPONSE MANAGEMENT
    8. VACCINATION
    9. SOCIAL AND INDUSTRY ASPECTS
    10. MONITORING AND PROOF OF FREEDOM
    1. Isolation and characterisation of an H3N8 equine influenza virus in Australia, 2007 (pages 35–37)

      J Watson, K Halpin, P Selleck, A Axell, K Bruce, E Hansson, J Hammond, P Daniels and M Jeggo

      Version of Record online: 28 JUN 2011 | DOI: 10.1111/j.1751-0813.2011.00738.x

    2. Validation of an influenza virus A 5′Taq nuclease assay for the detection of equine influenza virus A RNA in nasal swab samples (pages 39–42)

      J Oakey, T Hawkesford, C Smith, G Hewitson, X Tolosa, L Wright, N Moody, B Rodwell, B Corney and D Waltisbuhl

      Version of Record online: 28 JUN 2011 | DOI: 10.1111/j.1751-0813.2011.00747.x

  5. EPIDEMIOLOGY

    1. Top of page
    2. EDITORIAL
    3. OVERVIEW OF THE OUTBREAK
    4. CLINICAL ASPECTS
    5. LABORATORY ASPECTS
    6. EPIDEMIOLOGY
    7. RESPONSE MANAGEMENT
    8. VACCINATION
    9. SOCIAL AND INDUSTRY ASPECTS
    10. MONITORING AND PROOF OF FREEDOM
  6. RESPONSE MANAGEMENT

    1. Top of page
    2. EDITORIAL
    3. OVERVIEW OF THE OUTBREAK
    4. CLINICAL ASPECTS
    5. LABORATORY ASPECTS
    6. EPIDEMIOLOGY
    7. RESPONSE MANAGEMENT
    8. VACCINATION
    9. SOCIAL AND INDUSTRY ASPECTS
    10. MONITORING AND PROOF OF FREEDOM
  7. VACCINATION

    1. Top of page
    2. EDITORIAL
    3. OVERVIEW OF THE OUTBREAK
    4. CLINICAL ASPECTS
    5. LABORATORY ASPECTS
    6. EPIDEMIOLOGY
    7. RESPONSE MANAGEMENT
    8. VACCINATION
    9. SOCIAL AND INDUSTRY ASPECTS
    10. MONITORING AND PROOF OF FREEDOM
  8. SOCIAL AND INDUSTRY ASPECTS

    1. Top of page
    2. EDITORIAL
    3. OVERVIEW OF THE OUTBREAK
    4. CLINICAL ASPECTS
    5. LABORATORY ASPECTS
    6. EPIDEMIOLOGY
    7. RESPONSE MANAGEMENT
    8. VACCINATION
    9. SOCIAL AND INDUSTRY ASPECTS
    10. MONITORING AND PROOF OF FREEDOM
  9. MONITORING AND PROOF OF FREEDOM

    1. Top of page
    2. EDITORIAL
    3. OVERVIEW OF THE OUTBREAK
    4. CLINICAL ASPECTS
    5. LABORATORY ASPECTS
    6. EPIDEMIOLOGY
    7. RESPONSE MANAGEMENT
    8. VACCINATION
    9. SOCIAL AND INDUSTRY ASPECTS
    10. MONITORING AND PROOF OF FREEDOM

SEARCH

SEARCH BY CITATION